← Open Payments lookup

PHAEDRA MCLIN: Open Payments

NPI 1801298278 · PURVIS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$168 in 9 payments from 6 companies in 2025. Trend: 2023 $269 · 2024 $296 · 2025 $168

Food & beverage: $168
CompanyPaymentsAmount
Alkermes, Inc.2$39
Janssen Pharmaceuticals, Inc2$37
Lundbeck LLC2$30
Neurocrine BioSciences, Inc.1$22
Teva Pharmaceuticals USA, Inc.1$19
E.R. Squibb & Sons, L.L.C.1$19

Products named: ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, UZEDY, COBENFY.

Industry payments across MS — which companies pay providers there.